Raynaud's Syndrome - Biotech, Pharma and Life Science Channel

03:48 EDT 2nd April 2015 | BioPortfolio

PubMed Articles [4911 Associated PubMed Articles listed on BioPortfolio]

Obesity and anthropometric indicators in a sample of males with Acute Coronary Syndrome in a health area with inclusion of inmates: case-control study.

Obesity is a cardiovascular risk factor with a high epidemic burden on ischemic heart disease. The aim of this study was to analyze the anthropometric indicators of obesity in a sample of males who ha...

NUCKS: a potential biomarker in cancer and metabolic disease.

Nuclear, casein kinase and cyclin-dependent kinase substrate (NUCKS), a protein similar to the HMG (high-mobility group) protein family, is one of the most modified proteins in the mammalian proteome....

Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.

Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) are highly prevalent in the general population, with significant symptom overlap, whereas the interaction between both remains...

Gender disparities in acute coronary syndrome: a closing gap in the short-term outcome.

The aim of the present study was to analyze gender disparities in a large cohort of acute coronary syndrome (ACS) patients from the Zurich Acute Coronary Syndrome (Z-ACS) Registry.

Vitiligo in the Koolen-de Vries or 17q21.31 microdeletion syndrome.

Trigeminal Involvement in Parry-Romberg Syndrome: An In Vivo Confocal Microscopy Study of the Cornea.

Comparison of subacromial tenoxicam and steroid injections in the treatment of impingement syndrome.

This study aims to assess and compare the efficacy of subacromial tenoxicam and steroid injections in treating patients with shoulder impingement syndrome.

Hypothenar hammer syndrome: a case series and literature review.

This study aims to report our experience regarding patients who were surgically treated due to hypothenar hammer syndrome and review the related literature.

Defining the Adenoma Burden in Lynch Syndrome.

Patients with 10 or more lifetime adenomas are candidates for genetic counseling and testing for polyposis syndromes. Lynch syndrome falls under the umbrella of hereditary nonpolyposis colorectal canc...

Colonic Polyps in Lynch Syndrome.

News Articles [1220 Associated News Articles listed on BioPortfolio]

Fetal DNA tests prove highly accurate but experts warn of exceptions

CHICAGO, April 1 (Reuters) - A Roche blood test to screen fetuses for Down syndrome worked far better than standard prenatal screening tests in younger, low-risk women, U.S. researchers said on Wednes...

Newer Test for Down Syndrome Called 'Major Advance'

WEDNESDAY, April 1, 2015 -- A DNA-based blood test appears to be more effective in detecting possible Down syndrome in unborn children than other screening methods for the genetic disorder, researcher...

'Exploding Head Syndrome' Surprisingly Common Among Young People

WEDNESDAY, April 1, 2015 -- Nearly one in five young people suffers from what's called "exploding head syndrome," a new study suggests. People with the syndrome are startled awake from sleep by sudden...

Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept

Blood test trumps accuracy of standard screening in detecting Down syndrome in early pregnancy

A blood test undertaken between 10 to 14 weeks of pregnancy may be more effective in diagnosing Down syndrome and two other less common chromosomal abnormalities than standard non-invasive screening t...

Night owls face greater risk of developing diabetes than early risers

Night owls are more likely to develop diabetes, metabolic syndrome and sarcopenia than early risers, even when they get the same amount of sleep, according to a new study published in the Endocrine So...

Centrum Badan DNA partners with Premaitha Health to offer the IONA® test in Poland

Premaitha Health plc (“Premaitha”, AIM: NIPT) and Centrum Badan DNA group in Poland (“Centrum Badan”) announce today a collaboration agreement for Premaitha to supply its CE-ma...

Demystifying Facet Joint Syndrome

Spine specialist Dr. Kaixuan Liu with Atlantic Spine Center explains this common cause of back pain and offers tips for treatments. West Orange, NJ (PRWEB) April 01, 2015 When you’re suffering from...

Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym(R)

MENLO PARK, CA -- (Marketwired) -- 04/01/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre...

International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants

A UC Davis professor of genetics and pediatrics has received a nearly $4 million, five-year grant from the National Institute of Dental and Craniofacial Research to lead a team of physicians and scien...

Events [0 Results]

None

Companies [51 Associated Companies listed on BioPortfolio]

Newron Pharmaceuticals S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain. The Compan...

LYSOGENE

LYSOGENE is a clinical stage biotechnology company committed to the development and commercialization of innovative therapies for patients affected with rare disorders and high un...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Ou...

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical...

Ideal Protein

Ideal Protein is a medical weight loss program that was developed 23 years ago by physician Dr. Tran Tien Chanh. Ideal Protein is a medical solution protocol based on validated sc...

Cortendo AB

Cortendo AB is a biopharmaceutical company headquartered in Göteborg, Sweden. Its stock is publicly traded on the NOTC-A-list (OTC) in Norway. Cortendo is a pioneer in the fiel...

Innocrin Pharmaceuticals, Inc.

Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer. VT-464 an...

Sea-licious™

Karlene Karst, a Registered Dietician, is a leading health specialist in both nutrition and natural medicine. She is the co-author of the national best seller “Healthy ...

Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergyâ...

Sturge-Weber Foundation

Since its founding in 1987, the Sturge-Weber Foundation (SWF) has provided information, education and friendly support to adults and families of children with Sturge-Weber syndrom...

Clinical Trials [1971 Associated Clinical Trials listed on BioPortfolio]

Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in MPS IIIB

This study will evaluate the safety, pharmacokinetics, and pharmacodynamics/efficacy of IV administration of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU), referred to as SBC-1...

Homeopathic Treatment of Premenstrual Syndrome

The proposed study will focus on premenstrual syndrome (PMS) symptom alleviation for women diagnosed as suffering from the syndrome with the DRSP questionnaire. The women will be treated...

Echocardiography Predictive of the Inefficacy and/or of the Unsafeness of Recruitment Maneuvers in Patients With Acute Respiratory Distress Syndrome.

The purpose of the study RVSTAR is to evaluate whether echocardiographic criteria exploring the right ventricle can predict the inefficacy and/or the unsafeness of recruitment maneuvers in...

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

Prevention of cardiovascular events by antiplatelet agents after acute coronary syndrome

A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013)

The purpose of this trial is to evaluate the safety, tolerability, and efficacy of pembrolizumab (MK-3475) in hematologic malignancies (myelodysplastic syndrome [MDS], multiple myeloma [MM...

Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome

The study is a randomized, double-blind, placebo-controlled study in children with Alagille Syndrome (ALGS). The study will investigate the effects of LUM001, compared to placebo, on pruri...

Comparative Prevalence of Psychiatric Manifestations in Purely Obstetrical Antiphospholipid Syndrome

The main objective of this study is to estimate the lifetime prevalence of major psychiatric disorders (axis I DSM-IV; Diagnostic and Statistical Manual of Mental Disorders, version IV) in...

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IIB-IVB Mycosis Fungoides or Sezary Syndrome

This phase II trial studies how well pembrolizumab works in treating patients with stage IIB-IVB mycosis fungoides or Sezary syndrome that has returned after a period of improvement or has...

Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS

Fibrocyte is a monocyte sub-population involved in fibroproliferation/repair processes and associated with outcome in different diseases. In previous study, we have demonstrated the presen...

Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation

The goal of this clinical research study is to learn if 5-azacitidine and sorafenib can help to control the disease in patients with AML and high risk MDS with FLT3-ITD mutation. The safe...

Medical and Biotech [MESH] Definitions

An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.

A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention.

A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.

A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Raynaud's Syndrome market research data and corporate reports here

Channels Quicklinks